CareTrust REIT, Inc. (CTRE) — closed signal from March 8, 2026
Partial Published before the outcome was known, scored automatically when the window closed on June 6, 2026.
Predicted vs. what happened
What happened
Reached 72% of the predicted growth at its peak, without hitting the target.
The thesis — published March 8, 2026
CTRE looks like a reasonable short-term idea because the company is showing better operating results and analysts have raised their numbers. Being added to the S&P MidCap 400 could force some funds to buy the stock. Because it already moved up, it's safer to wait for a small pullback instead of buying at the top.
Primary drivers
- Improving earnings and upward analyst estimates
- Index addition should bring automatic buying from funds
- Growth from buying more healthcare properties keeps revenue visible
- Calmer price swings suit a short holding period
How it played out
CTRE: thesis partly played out, target missed
Lyra published CTRE on 2026-03-08 at 39.94 as a short-term idea with 11% expected growth. The thesis pointed to improving earnings, upward analyst estimates, possible automatic buying after S&P MidCap 400 addition, growth from buying more healthcare properties, and calmer price swings for a short holding period.
Inside the window, the stock rose, but it did not reach 44.33. Its best print was 43.08 on 2026-05-14, a 7.9% gain. It never got there. By 2026-06-06, CTRE ended at 37.97. The thesis partly played out on the move toward the target, but the published target was missed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.